Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle… - Jama, 2021 - jamanetwork.com
Importance The evidence for benefit of convalescent plasma for critically ill patients with
COVID-19 is inconclusive. Objective To determine whether convalescent plasma would
improve outcomes for critically ill adults with COVID-19. Design, Setting, and Participants
The ongoing Randomized, Embedded, Multifactorial, Adaptive Platform Trial for Community-
Acquired Pneumonia (REMAP-CAP) enrolled and randomized 4763 adults with suspected
or confirmed COVID-19 between March 9, 2020, and January 18, 2021, within at least 1 …
COVID-19 is inconclusive. Objective To determine whether convalescent plasma would
improve outcomes for critically ill adults with COVID-19. Design, Setting, and Participants
The ongoing Randomized, Embedded, Multifactorial, Adaptive Platform Trial for Community-
Acquired Pneumonia (REMAP-CAP) enrolled and randomized 4763 adults with suspected
or confirmed COVID-19 between March 9, 2020, and January 18, 2021, within at least 1 …
以上显示的是最相近的搜索结果。 查看全部搜索结果